Thursday, June 28, 2012
About the XanGo company
Xango is a private network marketing company located in Lehi, Utah.
Xango markets and also distributes a blended juice product called Xango juice consisting of mangosteen plus other juices, personal care, skin care, nutritional supplement and energy supplement products manufactured with botanical ingredients.
Xango was founded in 2002 by Gary Hollister, Joe Morton, Gordon Morton, Aaron Garrity, Bryan Davis and Kent Wood. The press releases from the company in 2005-2006 stated that in 2003 and 2004, its total sales were $40 million and $150 million respectively and in 2005, its sales were over two fold of those in 2004.
In October 2007, the cumulative sales for the company over a 5 year period were more than $1 billion and it had exceeded $1.5 billion by November 2008.
In November, the company had over 600 employees and over 500,000 independent distributors in fifteen international markets. In July 2007, the company had around 700,000 distributors, 70% of whom simply utilized their status to purchase the juice at discounted membership price.
In October 2008, the company operated in twenty four countries and had over one million independent distributors. Today, Xango operates in thirty six countries all over the world.
Xango Review – Products
Xango product lines include:
• Xango® Juice Line- includes Xango Juice, XangoReserve and Xango Single.
• Favao- includes Favao Body Cleanse, Favao Fiber, Favao Protein, Favao metabolic and Favao Lifestyle Program.
• Favao Pro- includes Favao Limitless • Eleviv
• Xango 3SIXTY5 Line- Includes Xango 3SIXTY5 and Xango 3SIXTY5 Kids.
• Glimpse Skin Care Line- Includes Complete System, System II, System I, Gel Cleanser, Creamy Cleanser, Toner, Moisturizing Lotion, Moisturizing Cream, Serum, Glimpse Brighten Glimpse Repair and Mineral Treatment.
• Precis™ Line- Includes Precis™ Bone Helath, Precis™ Men’s Health and Precis™ Omega 3.
• Juni® Line- Includes Clarifying Shampoo, Nourishing Shampoo, Clarifying Conditioner, Hand & Body Wash, Hand & Body Lotion and Nourishing Conditioner.
• Xango Meal Pack
Xango – Business Opportunity
Xango offers a unique business opportunity for people who want to sign up as a distributor. Their compensation plan suits both people who only want to earn some additional income part time, or for the serious network marketer that wants to get involved on a full time basis.
Wednesday, June 6, 2012
Medications Side Effects on Your Nutrition
This Great Blog posted by Vicki
discusses Medications Effect on Nutrition
Did you know that most OTC and prescription drugs deplete, or disable your body from absorbing, essential nutrients? In this way, they are doing you more harm than good.
For example, aspirin inhibits the body’s ability to absorb vitamin C, and can reduce the levels of iron and folic acid, causing anemia, and a compromised immune system.
Contraceptives deplete the body of vitamins B6, b!2, zinc, and blood magnesium, which can cause insomnia, mood swings, and diarrhea to name a few.
Acid blockers also reduce levels of iron and zinc. Zinc is important in high levels to fight off infection, and also important for prostate health, and is concentrated most in men in their prostate.
For a more complete list, check out this Perscription Drug Depletion Chart, and OTC Medication Depletion Chart.
To Your Health!
If You Enjoyed This, Please Share!
Tuesday, May 29, 2012
XanGo ranks first in taste test!
Another XANGO First
By: Dave Webb, VP of Communications in: Featured, In The Media, News & Information, Press, XANGO Juice, XANGO Products
Published on: April 10, 2012
… Another first-place finish, that is:
An independent group called MLM Corporate Network recently performed a blind taste test of six network marketing juices, and (do we even need a drum roll?)… XANGO® Juice took top honors!
The judges on the tasting panel had no previous juice-supplement experience, and they rated things like appearance, aroma, taste, etc. The judges were given 3-oz servings of each juice, in a generic container, so they couldn’t even be influenced by our awesome bottle and our bowl-you-over nutrition facts. Just the juice, baby!
Congratulations to us! Click here to read the actual report.
WAY TO GO, XANGO!
Read more at XANGOSPHERE: http://blog.xango.com/products/another-xango-first/#ixzz1wHjUjPo7
Thursday, May 17, 2012
Increase your Productivity
A search on Amazon.com for books on Productivity returns 45,960 titles. If you’re having trouble being productive at work you may find it difficult to make the time to read a book on productivity cover to cover.
For that reason, I’m going to share with you 5 proven tactics that you can start implementing today that WILL enable you to increase your productivity and help you to get more done.
5 Proven Tactics to Increase Your Productivity
1. Wake Up Early
The morning provides a calm that is often hard to find at any other time of day. Phones aren’t ringing, emails are only starting to trickle, and not gush in, as they do later in the day. This is your time to get ahead. Use this time to exercise, read or study, and to get a jumpstart on your most important task of the day.
2. Start with Important Work
Our most meaningful and impacting projects are often the hardest and require the most time and attention. That’s why they often end up getting pushed lower and lower on our to-do list throughout the day. Take a new approach and start your day by focusing on your most important work first. You may find it hard to get going, but once you do you’ll be working on tasks that have meaning and provide a real impact to your business and career. Plus, once you get through your most important item you’ll feel liberated and can move on to the less important work that so often clogs the day.
3. No Interruptions
Robin Sharma points to research data that says workers are interrupted every 11 minutes. Every distraction reduces your productivity and derails your focus and energy from the task at hand. Value your work and value your time by saying NO to interruptions. Close your door, create a “Do Not Disturb” sign if you need one, and block your calendar with work times so your assistant or co-workers know not to bother you. There are so many interruptions around us each day. Find what they are in your life and start removing them.
4. Avoid Meetings
Daily and weekly meetings can be critical to keep the flow and rhythm in a business. But meetings where several people need to spend 20, 30 minutes to an hour or more need to be avoided like the plague. Not only do these meetings often result with few actionable ideas, the topics they cover can usually be dealt with over a 5 minute phone call. In fact, Seth Godin goes as far as saying he won’t attend meetings (at least in the typical sense) but prefers conversations where a decision can be reached. If not, meetings simply become events. Think about how much money is “invested” into a meeting when you have 4-5 employees sitting around a table for 30 minutes or an hour.
5. Disconnect the Internet
Stop swearing at me! Seriously, I know you NEED the internet. In a CNN survey many respondents said they would take the Internet over Sex any day. I digress. While the Internet does increase your productivity and allows for access to information in unimaginable ways, it continues to lower the productivity of many workers. How often do you get a notification of a new email? Engaged in research and come upon a Youtube video that you just “needed to watch”? Had to update your Facebook or Twitter status because you just found the cutest cat picture ever? You get the point, right? Unplugging yourself by taking your work offline provides a level of focus that you just can’t achieve online with all the potential distractions it presents.
Start by implementing one of these tactics today. You’ll start seeing positive results and will quickly move to implementing more of them.
To a more productive you!
How do you increase your productivity? We’re curious to hear your tips!
Photo by David Castillo Dominici.
Tuesday, May 1, 2012
Celebrate Cinco de Mayo
I am sharing this wonderful post by Written by Sharon Palmer, RD and Briana Austin, Dietetic Intern
Celebrate Cinco de Mayo with Tomato Products!
May 1, 2012 by tomatowellness
Monday, April 23, 2012
Empowering women through XanGo
This Post is i to provide insight about the one of the leaders of XANGO, LLC, Senior VP Beverly Hollister. Beverly was named the 16th most influential woman in global direct selling in the annual Power 30 list by leading industry resource DirectSellingLive.com. Recognizing Hollister's three decades of creating best-selling products in the health and wellness industry, the publication highlighted her creation of XANGO's lines of natural, toxin-free personalcare products. Most recently, Hollister's leadership in product development led to XANGO's being named a "Champion of Safe Cosmetics" by the Campaign for Safe Cosmetics; additionally, Hollister has helped XANGO form a global women's empowerment initiative titled "Women Building Bridges."
"Beverly is an inspiration to everyone she meets, including me and my partners, our employees and the millions of independent XANGO Distributors around the world," said XANGO Founder, Chairman and CEO Aaron Garrity. "Her vision and leadership compels all of us at XANGO to strive for the healthiest, natural formulations in our personal care products, and her energy and partnership with women around the world empowers them to achieve their dreams."
A conscious leader, Hollister continues to grow the Glimpse® and Juni® lines of personal care products, formulated using green chemistry to avoid harsh chemicals. When not launching products, Hollister travels the globe supporting XANGO Distributor leaders with mentorship and empowering events titled "Women Building Bridges," which bring together Distributor leaders in XANGO to teach best practices and inspire women to achieve their success and dreams in life. Thus far, "Women Building Bridges" has hosted events across the U.S., Canada, Russia, Ukraine, Kazakhstan, Italy, France, Belgium, Portugal and many other XANGO markets. The global event this year is held in Carefree, Arizona, on May 18 through 20 - for more information, go to www.womenbuildingbridges.com .
A responsible products thought leader with an active role in the Campaign for Safe Cosmetics and the Breast Cancer Network, Hollister is a member of the American Management Association, the National Association for Female Executives, Lexington Who's Who and Cosmetic Executive Women. She has also been recognized by UtahBusiness Magazine as one of the most Powerful Women in Utah as well as a Woman to Watch.
About XANGO, LLC
A leading global nutrition company, XANGO, LLC, is a recognized leader in health and wellness products. Currently expanding into a wider range of botanicals, XANGO was the first company to market a premium mangosteen beverage, XANGO® Juice, to consumers worldwide. Its roster of premium, functional products now includes FAVAO(TM) by XANGO, XANGO® Reserve, the XANGO 3SIXTY5(TM) multi-vitamin with a powerful Active Defense Complex featuring Primactive(TM), Glimpse® Topical Skin Nutrition, Eleviv® for natural, youthful vigor, and Juni by XANGO® Family Care with natural, toxin-free personal-care products for the entire family. XANGO is privately owned and powered by a global network of more than 1 million independent distributors in the U.S. and 40 international markets including Canada, Mexico, Japan, Germany and Malaysia. For details, visit www.mymangosteen.com/podski
Story courtesy of XANGO, LLC
Tuesday, April 10, 2012
The benefits of Mangosteen Juice on the Cardiovascular System.
I found this paper Called
Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study
Authored by: Jay K Udani, Betsy B Singh, Marilyn L Barrett and Vijay J Singh
The ability to reduce inflammation in overweight and obese individuals may be valuable in preventing the progression to metabolic syndrome with associated risks for heart disease and diabetes. The purpose of this study was to evaluate the effect of multiple dosages of a proprietary Mangosteen Juice blend on indicators of inflammation and antioxidant levels in obese patients with elevated C-reactive protein (CRP) levels.
Methods
The study was an 8 week randomized, double-blind, placebo-controlled study with a pre-study 2 week washout period. The study included four groups including placebo and three difference doses of the test product, XanGo Juice™: 3, 6 or 9 oz twice daily. The primary outcome measure of this study was high-sensitivity (HS)-CRP. Secondary outcome measures included other biochemical indicators of inflammation, anthropomorphic measures and a safety evaluation.
Results
One hundred twenty two (122) persons were screened for the study, 44 were randomized and 40 completed the study. HS-CRP measurements dropped after 8 weeks treatment compared to baseline in all 3 dose groups and increased in the placebo group. The changes from baseline were not significant but the comparison of change from baseline was significant for the 18 oz group when compared to placebo (p = 0.02). Other markers of inflammation (inflammatory cytokines) and a marker for lipid peroxidation (F2 isoprostane) did not show any significant differences when compared with placebo. There was a trend towards a decrease in BMI in the juice groups. There were no side effects reported in any of the groups and none of the laboratory or EKG safety assessments indicated clinically significant changes for any subject.
Conclusion
In this pilot, dose-finding study, a proprietary mangosteen juice blend (XanGo Juice™) reduced CRP levels (increased change from baseline) compared to placebo for those taking the highest dose of 18 oz per day. Further studies with a larger population are required to confirm and further define the benefits of this juice. The juice was administered safely.
Trial Registration
ISRCTN9300027
Background
Obesity is a complex and difficult disorder which is multi-factorial in its etiology. Central adipose tissue is known to produce adiponectin, which plays a role in the glucose/insulin axis as well as the production of inflammatory cytokines. When central adipose tissue expands through increased fat deposition, it appears that there is a concomitant drop in the production of adiponectin along with a rise in the expression of inflammatory cytokines and C-reactive protein (CRP) [1]. Inflammation is emerging as a predictor of cardiovascular disease and may be considered a precursor of metabolic syndrome. Therefore the ability to reduce inflammation (as measured by CRP) in overweight and obese individuals may be valuable in preventing the progression to diabetes [2,3] and heart disease [4-10]. Inflammation has also been implicated in lung disease[11-13], diseases of the digestive tract [14], skin diseases [15-18], and arthritis [19-24].
There are many options in the treatment of inflammation. Steroids have been used, but are best in acute inflammatory presentation as there are potential side effects from long term use, including poor resistance to infection. Often inflammation is treated initially with nonsteroidal inflammatory drugs (NSAIDS) such as ibuprofen, naproxen and aspirin [24]. However, these drugs also have potential side effects such as gastrointestinal bleeding. A series of cyclooxygenase (COX)-2 inhibitors have been marketed in recent years, but they too have had issues related to side effects that require monitoring [24,25]. These issues were the impetus for investigation of traditional medical (Ayurveda and Traditional Chinese Medicine) herbal products which may offer products that have anti-inflammatory benefit with a lower risk-profile [26].
Mangosteen fruits, Garcinia mangostana L. [Guttiferae], were mentioned in Chinese medicinal records dating back to the Ming dynasty (1360 to 1644 AD). Alpha- and γ-mangostins from G. mangostana are identified as bioactive substances with anti-inflammatory effects [27]. The anti-inflammatory mechanism appears to be inhibition of the conversion of arachadonic acid to prostaglandin (PG)E2 by COX [28,29] and blocking of inhibitor kappa-B kinase (IKK) activity. IKK prevents nuclear factor kappa B (NFκB) dependent COX-2 gene transcription [30]. In addition, the γ-mangostin xanthone has been shown to inhibit lipopolysaccharide (LPS) induced activation of IKK, NFκB and human COX-2 gene promoter region dependent transcription, but had no effect on COX-1 [31]. Anti-inflammatory activity was also demonstrated in-vivo with γ-mangostin using the rat paw edema model [31].
XanGo Juice™ contains a whole fruit puree of the mangosteen in addition to other fruit juices. The purpose of this study was to evaluate the efficacy of multiple dosages of XanGo Juice compared with placebo in the improvement of inflammation and antioxidant levels in obese patients with elevated CRP levels.
Methods
Study Design
The study was an 8 week randomized, double-blind, placebo-controlled study with a pre-study 2 week washout period. The study was conducted at a single site: Medicus Research, LLC, in Northridge, Ca. Sample size was not calculated as this was an exploratory trial to compare three concentrations of the target product to placebo. The study was approved by the Copernicus Group IRB (Cary, NC) prior to the initiation the study.
Recruitment
Subjects were serially recruited if they were between 30-75 years of age, had a body mass index (BMI) ≥ 30 and ≤ 45 kg/m2 (obese), a HS-CRP of ≥ 3, agreed to discontinue anti-inflammatory medications and supplements (other than daily 81 mg aspirin which was allowed), agreed to use approved birth control methods if a female of childbearing age, and agreed to not initiate or change any exercise or diet programs during the study. Subjects were excluded if they had consumed the test product in the past, had allergies to the test product, using any drugs that can affect CRP, were taking hormone replacements, anticoagulant or anti-platelet therapy, had surgery in the past 6 months, smoked cigarettes, known alcohol or drug abuse, had major systemic, inflammatory or chronic disease, untreated depression, active eating disorder, were unable to understand or follow study protocol, were pregnant or lactating and had any medical condition which in the opinion of the investigator might interfere with the subject's ability in the trial.
Clinical Study Process
The subjects in the study came to the research clinic for a total of 4 visits (V0-V3). At (V0), the screening visit, subjects were screened for eligibility according to the inclusion/exclusion criteria. Subjects gave their informed written consent before any procedures were conducted. There was a 2 week washout phase between screening and enrollment during which subjects were asked to refrain from consuming dietary supplements (including anti-oxidants) and anti-inflammatory medications. The baseline visit (V1) took place after the washout period with subjects in a fasted state (10 hours). During this visit, the subjects underwent a physical examination, had their blood drawn and were randomized into groups. The laboratory tests and procedures included HS-CRP and a cytokine panel via Sandwich Immunoassay (Panomics, Inc., San Diego, CA), Urine F2 isoprostane (Kronos Science Laboratory, Phoenix, AZ), and safety laboratory assessments including complete blood count (CBC), comprehensive metabolic panel (CMP), and urinalysis (Primex Labs, Northridge, CA) and platelet aggregometry (Plateletworks, Helena Laboratories, Beaumont, TX). These lab tests were repeated at the 4 week (V2) and 8 week (V3) visits. An EKG was performed at baseline (V1) and again at 8 weeks (V3). During all 4 visits, anthropomorphic measures (hip and waist measurements, and weight) were obtained and vital signs (blood pressure, temperature, pulse, and respiration) were checked. Adverse event monitoring was performed at each visit using a standardized set of questions. Subjects were instructed not to change their diet nor start any new exercise program during the course of the study. In order to assess compliance, subjects were required to return all unused investigational product at each visit.
Outcome Measures
The primary outcome measure of this study was HS-CRP, a marker of cardiac health related to inflammation. Secondary outcome measures were inflammatory cytokines, urine F2 isoprostane (a measure of lipid peroxidation) and anthropomorphic measures (weight, waist and hip measurements, BMI, and body fat percentage). Safety evaluations included CBC, CMP, EKG, urinalysis and platelet aggregation, as well as particular attention to potential gastrointestinal or cardiovascular related signals.
Randomization
Subjects were randomized using a table of random numbers derived from a random number generating program. A simple randomization schema utilizing 4 groups was given to the clinical staff. A single master sheet was used to randomize subjects if they were eligible for inclusion in the study following the clinical screen. The master sheet included subject number, coordinator initials and date of randomization was used to track the process and insure no duplications of assignment. None of the clinical staff had access to the assignment code key.
Product Description
The test product was XanGo Juice™ produced by XanGo, LLC. The primary ingredient of XanGo Juice was mangosteen (Garcinia mangostana L.) whole fruit puree. XanGo Juice also contained apple fruit juice, pear fruit juice, grape fruit juice, pear fruit puree, blueberry fruit juice, raspberry fruit juice, strawberry fruit juice, cranberry fruit juice, and cherry fruit juice. The placebo consisted of water, sucrose (3 g/30 ml), citric acid, red grape juice concentrate, fiber complex, grape skin, natural flavors, red #40, cloud (ester gum), whey protein isolate, sodium benzoate, xanthan gum, blue #1, and caramel color.
Three different dosages of the juice were tested and compared to placebo. The product doses tested were 3 oz, 6 oz and 9 oz. All doses and placebo were consumed in a total of 9 oz of liquid in identical bottles. The placebo was used to make up the volume for the lower doses. Subjects were instructed to consume the assigned drink twice a day, once in the morning and again in the evening. They therefore took a total of 0 to 18 oz of active product per day in 18 oz of fluid.
Data Management
The data from the field activity at the Northridge, CA. site was received at the CRO facility of Medicus Research, LLC in Midlothian, VA using password protected electronic transfer. The Data Management staff logged in the data files as they were received; code books were developed to facilitate smooth and accurate editing and data entry. Statistician and Data Analyst trained the data entry personnel using the codebook as the guideline for instruction on operational processes for this data. Data was analyzed using paired sample t-tests for within subject means comparisons, independent sample t-tests for between group comparisons (Placebo vs. each of the active groups individually), t-tests of difference scores for both within and between group comparisons (Placebo vs. each of the active groups individually).
Data was analyzed with the CRO team continuing the 'blinded' structures concerning group assignment. The analysis team only had the Placebo group identified to them so that they would know how to organize the statistical comparisons. Only after the analysis was completed was the 'blind' broken in order to properly report relationships between the 3 different strengths of the product being tested and placebo.
Excel 2003 (Microsoft Corp, Redmond WA), was used for data entry, validation, restructuring, calculating changes in variables over time, reorganizing and reformatting results, and preparing graphs. Statistical analyses (descriptive statistics and means comparison tests, both within and between group, were performed using SPSS Base System ver. 16 (SPSS Inc., Chicago IL.)
Results
One hundred twenty two persons were screened for the study, 44 were randomized and 40 completed the study. Two subjects withdrew from the study due to family related issues, and two subjects were administratively withdrawn for noncompliance. The groups were not significantly different at baseline on age, gender, CRP, BMI, or percentage body fat (Table 1). List wise deletion was utilized in the analysis of study data as each of the 4 groups had a sample size of less than 20.
The full text can be found at http://www.nutritionj.com/content/8/1/48
Subscribe to:
Posts (Atom)